Tesamorelin (10mg)

$70.00
sold out

Tesamorelin in a laboratory-formulated synthetic peptide supplied exclusively for controlled research use. Classified as a growth hormone secretagogue, this compound is studied in in vitro environments for its interaction with growth-hormone releasing pathways under defined experimental conditions.

Tesamorelin in a laboratory-formulated synthetic peptide supplied exclusively for controlled research use. Classified as a growth hormone secretagogue, this compound is studied in in vitro environments for its interaction with growth-hormone releasing pathways under defined experimental conditions.

Research-Grade Growth Hormone Releasing Peptide

Tesamorelin is a synthetically engineered peptide analog of Human Growth Hormone-Releasing Hormone (GHRH), supplied exclusively for laboratory research use. As a growth hormone secretagogue, Tesamorelin interacts with specific receptor pathways involved in endogenous growth hormone regulation under tightly controlled experimental conditions. Its defined molecular composition and stability make it a valuable research compound for in vitro and preclinical studies exploring hormone signaling behavior and metabolic regulation.

Research Applications

In laboratory research, Tesamorelin is studied for its mechanism of action as a GHRH analog that stimulates receptors in the anterior pituitary gland to promote the synthesis and release of endogenous growth hormone. This peptide is particularly relevant in studies that examine:

  • Growth hormone synthesis and release pathways

  • Receptor-mediated signaling mechanisms

  • Insulin-like growth factor-1 (IGF-1) regulation

  • Metabolic process modulation in controlled systems

  • Peptide-receptor interaction dynamics

Researchers leverage Tesamorelin in experimental setups designed to observe how growth hormone axis modulation influences downstream molecular events under defined laboratory conditions. Its ability to mimic natural hormone activity while maintaining structural integrity supports reproducible and controlled research workflows.

Mechanism and Molecular Profile

Tesamorelin is a 44-amino-acid peptide analog structurally modified to enhance stability and resist rapid enzymatic degradation relative to endogenous GHRH. It functions by binding to growth hormone-releasing hormone receptors, triggering intracellular cascades that lead to increased growth hormone secretion. Elevated growth hormone subsequently influences IGF-1 levels and is associated with metabolic processes such as lipolysis and protein synthesis in research models.

Laboratory Formulation and Preparation

This research peptide is supplied as a lyophilized powder to support stability during storage and transport. Such preparation helps preserve compound integrity and allows your laboratory to reconstitute solutions using appropriate research-grade solvents according to internal protocols. Standardized handling and preparation practices contribute to consistent experimental outcomes.

Storage Recommendations

For optimal preservation of structural and functional characteristics, Tesamorelin should be stored in a cool, dry environment away from direct light exposure. Proper environmental control helps maintain peptide stability over extended periods.

Quality Standards

Each batch of Tesamorelin is produced under strict quality control standards to ensure consistency in research supply. Analytical verification prior to release confirms that material specifications align with documented composition and purity expectations.

Research Use Statement

This compound is supplied strictly for laboratory research purposes and is not intended for human or veterinary use.